These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 17983944)
41. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761 [TBL] [Abstract][Full Text] [Related]
42. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978 [TBL] [Abstract][Full Text] [Related]
43. Imaging to optimally stage lung cancer: conventional modalities and PET/CT. Truong MT; Munden RF; Movsas B J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738 [TBL] [Abstract][Full Text] [Related]
45. The role of VATS for staging and diagnosis in patients with non-small cell lung cancer. Howington JA Semin Thorac Cardiovasc Surg; 2007; 19(3):212-6. PubMed ID: 17983947 [TBL] [Abstract][Full Text] [Related]
46. CT, positron emission tomography, and MRI in staging lung cancer. Erasmus JJ; Sabloff BS Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183 [TBL] [Abstract][Full Text] [Related]